£57.97

Springer Biologie und Epidemiologie der Hormonersatztherapie - Biology and Epidemiology of Hormone Replacement Therapy: Diskussionen zur Postmenopausalen ... Foundation Symposium Proceedings, 13)

Price data last checked 48 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 43 days • 43 data points (No recent data available)

Historical
Generating forecast...
£57.97 £49.85 £51.62 £53.39 £55.17 £56.94 £58.71 25 January 2026 04 February 2026 15 February 2026 25 February 2026 08 March 2026

Price Distribution

Price distribution over 43 days • 4 price levels

Days at Price
Current Price
3 days 17 days 22 days 1 day · current 0 6 11 17 22 £51 £52 £57 £58 Days at Price

Price Analysis

Most common price: £57 (22 days, 51.2%)

Price range: £51 - £58

Price levels: 4 different prices over 43 days

Description

Die Vor- und Nachteile der Hormonersatztherapie (HRT) werden von einer Expertengruppe hinsichtlich der epidemiologischen Beweislage diskutiert. Obwohl alle positiven und negativen Aspekte der HRT behandelt werden, liegt der Schwerpunkt der Diskussionen bei der Frage des Brustkrebsrisikos. Unter anderem wird gezeigt, dass die aus epidemiologischen Studien abgeleiteten Ergebnisse sich nicht mit den Wachstumseigenschaften dieser Tumoren decken so dass weiterführende Bevölkerungsuntersuchungen unter Einbeziehungen pathobiologischen Sachverstands notwendig erscheinen. This volume contains an advanced level discussion on the appropriateness of hormone replacement therapy (HRT) in modern postmenopausal women on the basis of the current evidence provided by recent epidemiological studies. It addresses all aspects of benefits and risks associated with HRT, including issues concerning psychology, the cardiovascular system, bone structure, and carcinogenesis. It focuses, however, on cancer risk and on risk of breast cancer in particular. In doing so, it provides a detailed discussion of the pathobiological features of breast cancer, concluding that the evidence provided by epidemiological studies is in conflict with the biological growth features of breast cancer. It advocates further epidemiological studies which incorporate pathobiological assessments.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
25 July 2006
Listed Since
31 December 2006

Barcode

No barcode data available

Similar Products You Might Like

CRC Press Hormone Replacement Therapy and Cancer Textbook
93% match

CRC Press Hormone Replacement Therapy and Cancer Textbook

CRC Press

£51.17 20 Apr 2026
Springer - Therapeutic Resistance to Anti-hormonal Drugs Book
92% match

Springer - Therapeutic Resistance to Anti-hormonal Drugs Book

Springer

£113.78 14 Apr 2026
Springer Sex Hormone Replacement Therapy - Endocrine Updates 8
91% match

Springer Sex Hormone Replacement Therapy - Endocrine Updates 8

Springer

£113.48 19 Apr 2026
Springer Sex Hormone Replacement Therapy - Endocrine Updates 8
91% match

Springer Sex Hormone Replacement Therapy - Endocrine Updates 8

Springer

£120.71 19 Apr 2026
Modern Menopausal Hormone Treatment: Facts and Myths About Sex Hormones
91% match

Modern Menopausal Hormone Treatment: Facts and Myths About Sex Hormones

Springer

£57.80 25 Jan 2026
Focus on Hormone Replacement Research
91% match

Focus on Hormone Replacement Research

£54.41 11 Feb 2026
Hormonal Pathology of the Uterus: 1242 (Advances in Experimental Medicine and Biology, 1242)
91% match

Hormonal Pathology of the Uterus: 1242 (Advances in Experimental Medicine and Biology, 1242)

Springer

£77.20 24 Feb 2026
Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)
91% match

Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)

Springer

£77.58 23 Feb 2026
Hormone Therapy in Breast and Prostate Cancer (Cancer Drug Discovery and Development)
91% match

Hormone Therapy in Breast and Prostate Cancer (Cancer Drug Discovery and Development)

Humana

£60.74 10 Mar 2026
Biological and Hormonal Therapies of Cancer: 94 (Cancer Treatment and Research, 94)
91% match

Biological and Hormonal Therapies of Cancer: 94 (Cancer Treatment and Research, 94)

Springer

£141.36 11 Jan 2026
Hormones and Cancer: Breast and Prostate, An Issue of Endocrinology and Metabolism Clinics of North America (Volume 40-3) (The Clinics: Internal Medicine, Volume 40-3)
91% match

Hormones and Cancer: Breast and Prostate, An Issue of Endocrinology and Metabolism Clinics of North America (Volume 40-3) (The Clinics: Internal Medicine, Volume 40-3)

Saunders

£61.52 05 Mar 2026
Biological and Hormonal Therapies of Cancer: 94 (Cancer Treatment and Research, 94)
91% match

Biological and Hormonal Therapies of Cancer: 94 (Cancer Treatment and Research, 94)

Springer

£201.60 07 Jan 2026
Endocrine Therapy of Breast Cancer V (ESO Monographs)
91% match

Endocrine Therapy of Breast Cancer V (ESO Monographs)

Springer

£77.78 05 Mar 2026
Breast Cancer: Molecular Genetics, Pathogenesis, and Therapeutics (Contemporary Cancer Research)
91% match

Breast Cancer: Molecular Genetics, Pathogenesis, and Therapeutics (Contemporary Cancer Research)

Humana

£162.59 10 Mar 2026
ESTROGEN PREVENTION FOR BREAST (Cancer Etiology, Diagnosis and Treatments)
91% match

ESTROGEN PREVENTION FOR BREAST (Cancer Etiology, Diagnosis and Treatments)

£74.09 17 Feb 2026
Techniques and Methodological Approaches in Breast Cancer Research
91% match

Techniques and Methodological Approaches in Breast Cancer Research

Springer

£110.73 30 Jan 2026
Springer - Role of the Transcriptome in Breast Cancer Prevention
91% match

Springer - Role of the Transcriptome in Breast Cancer Prevention

Springer

£108.62 24 Feb 2026
Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)
91% match

Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)

Springer

£75.66 01 Mar 2026
Resistance to Aromatase Inhibitors in Breast Cancer: 8 (Resistance to Targeted Anti-Cancer Therapeutics, 8)
91% match

Resistance to Aromatase Inhibitors in Breast Cancer: 8 (Resistance to Targeted Anti-Cancer Therapeutics, 8)

Springer

£60.65 16 Mar 2026
Non–Reproductive Actions of Sex Steroids: No. 191 (Novartis Foundation Symposia)
90% match

Non–Reproductive Actions of Sex Steroids: No. 191 (Novartis Foundation Symposia)

Wiley-Blackwell

£90.00 09 Mar 2026
Springer - Making Babies: Biomedical Technologies and Ethics
90% match

Springer - Making Babies: Biomedical Technologies and Ethics

Springer

£120.99 24 Feb 2026
Ein Jahrhundert endokrine Therapie des Mammakarzinoms: Von Beatson bis heute
90% match

Ein Jahrhundert endokrine Therapie des Mammakarzinoms: Von Beatson bis heute

Springer

£46.99 07 Mar 2026
Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine: 1026 (Advances in Experimental Medicine and Biology, 1026)
90% match

Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine: 1026 (Advances in Experimental Medicine and Biology, 1026)

Springer

£110.00 09 Mar 2026
Neue Konzepte der Diagnostik und Therapie des Mammakarzinoms: Bericht über die 1. wissenschaftliche Tagung der Deutschen Gesellschaft für Senologie: Vor- und Frühstadien des Mammakarzinoms
90% match

Neue Konzepte der Diagnostik und Therapie des Mammakarzinoms: Bericht über die 1. wissenschaftliche Tagung der Deutschen Gesellschaft für Senologie: Vor- und Frühstadien des Mammakarzinoms

Springer

£43.23 07 Mar 2026